*Monday , March 27, 2006*
MADISON, Wis. — Stem cell patents held by a University of Wisconsin
organization are so restrictive that they create an impediment to
research, according to a science journal published Friday.
The authors, California stem-cell researcher *Jeanne F. Loring*
<javascript:siteSearch('Jeanne F. Loring');> and patent attorney
*Cathryn Campbell* <javascript:siteSearch('Cathryn Campbell');>, said
the Wisconsin Alumni Research Foundation <http://www.warf.ws/> patented
stem cells so broadly that other researchers can do little without
infringing on the foundation's patents.
The article appears in Friday's issue of the journal Science
<http://www.sciencemag.org/>.
Researchers value human embryonic *stem cells*
<javascript:siteSearch('stem cells');> because the generic cells hold
promise for curing diseases such as diabetes, Alzheimer's and
Parkinson's diseases.
The University of Wisconsin <http://www.wisc.edu/> has owned patents on
the cells ever since UW-Madison researcher *James Thomson*
<javascript:siteSearch('James Thomson');> first figured out how to grow
them in his lab in 1998.
The patents cover not only the cells but also the technique Thomson used
to derive and grow them. That means most stem cell research across the
country falls under the foundation's restrictions.
Carl Gulbrandsen, the foundation's executive director, said other
universities would have also protected its rights to such a breakthrough.
"I'm not embarrassed at all to say that I hope the University of
Wisconsin will make a whole lot of money from these patents," he said.
Initially, the foundation charged universities $5,000 to use the cells.
Later, an agreement with the National Institutes of Health
<http://www.nih.gov/> brought the price down to $500.
The foundation charges private labs up to $125,000 for the cells, plus
an annual maintenance fee of up to $40,000. The fees vary depending on
the size of the firms.
The fees also cover training to teach licensees how to maintain the
finicky cells, Gulbrandsen added.
Loring and Campbell are not the first researchers to claim the dollar
amounts impede research.
Doug Melton, who chairs Harvard University's department of molecular and
cellular biology, agreed that the foundation's patents are too restrictive.
Harvard has its own stem-cell program and distributes its lines for
free, but recipients are still bound by the foundation's restrictions.
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
